THROMBOLEX™ Inc. First Patient Enrolled in the RESCUE Trial for Treatment of Acute Submassive Pulmonary Embolism - PR.com

THROMBOLEX™ Inc. First Patient Enrolled in the RESCUE Trial for Treatment of Acute Submassive Pulmonary Embolism  PR.com

Comments

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review